Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Severe Proteinuria Due to Idiopathic Membranous Nephropathy

Tundra lists 1 Severe Proteinuria Due to Idiopathic Membranous Nephropathy clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT04456816

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

This study is an exploratory, randomized, double-blind, multicenter, placebo-controlled study with repeated doses of AP1189. The study population will consist of patients with idiopathic membranous nephropathy (iMN) and severe proteinuria who are on ACE inhibitor or angiotensin II receptor blocker treatment.

Gender: All

Ages: 18 Years - 85 Years

Updated: 2026-03-06

Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy

Severe Proteinuria Due to Idiopathic Membranous Nephropathy